Safety In Pharma And Healthcare: Improving Detection Of Legionellosis Causing Bacteria

 

Many healthcare and pharmaceutical facilities are required to control, monitor and test for the bacteria responsible for causing the collective diseases known as ‘legionellosis’, of which Legionnaires' disease (a form of atypical pneumonia), Pontiac fever (an acute respiratory disease) and Lochgoilhead fever (a variation of Pontiac fever) are the most serious. In particular, Legionnaires' disease is by far the most serious, presenting as a potentially fatal form of pneumonia. While the disease can affect any person, people with impaired lung function (such as those with chronic respiratory and smokers) and the elderly are especially vulnerable.

 

 

This IVT article examines the cause of infection and considers emerging technologies for improving testing, which advances the rapid microbiology paradigm.

 

Reference:

 

Sandle, T. (2021) Safety In Pharma And Healthcare: Improving Detection Of Legionellosis Causing Bacteria, IVT Network, 16^th August 2021, at: https://www.ivtnetwork.com/article/safety-pharma-and-healthcare-improving-detection-legionellosis-causing-bacteria

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)